Cart
sales@molnova.com
LDN-27219
CAS No. 312946-37-5
LDN-27219( —— )
Catalog No. M22644 CAS No. 312946-37-5
LDN-27219 is a potent hTGase inhibitor with IC50 of 0.6 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 62 | In Stock |
|
| 5MG | 58 | In Stock |
|
| 10MG | 88 | In Stock |
|
| 25MG | 155 | In Stock |
|
| 50MG | 229 | In Stock |
|
| 100MG | 344 | In Stock |
|
| 200MG | 505 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLDN-27219
-
NoteResearch use only, not for human use.
-
Brief DescriptionLDN-27219 is a potent hTGase inhibitor with IC50 of 0.6 uM.
-
DescriptionLDN-27219 is a potent hTGase inhibitor with IC50 of 0.6 uM.
-
In VitroLDN-27219 (30 μM; 12 min) promotes the closed conformation of TGase 2 to activates calcium-activated potassium channels in smooth muscle cells.LDN-27219 (30 μM; 20-25 min) increases the response to acetylcholine in phenylephrine-contracted human subcutaneous arteries.
-
In VivoLDN-27219 (0.1-2 mg/kg; i.v. once) affects vivo arterial pressure and shows larger effects on older rats. Animal Model:12 to 14-week-old male Wistar rats Dosage:0.1, 1 and 2 mg/kg Administration:Intravenous injection; 0.1, 1 and 2 mg/kg once Result:Dose-dependently decreased mean arterial pressure of mice.Animal Model:12 to 14- and 35 to 40-week-old male Wistar rats Dosage:0.1, 1 and 2 mg/kg Administration:Intravenous injection; 0.1, 1 and 2 mg/kg once Result:Decreased mean arterial pressure in old group more significant than young group.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorhTGase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number312946-37-5
-
Formula Weight408.5
-
Molecular FormulaC20H16N4O2S2
-
Purity>98% (HPLC)
-
SolubilityDMSO:122 mg/mL (298.65 mM)
-
SMILESNNC(=O)CSc1nc2scc(-c3ccccc3)c2c(=O)n1-c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
UC-1728
UC-1728 is an effective rabbit soluble epoxide hydrolase inhibitor (IC50: 2 nM on rabbit liver). Rabbits were treated by subcutaneous injection with the sEH inhibitor (UC1728, 3 mg/kg), or the vehicle control (PEG400) and uveitis was assessed at 6, 24 and 48 h post-intracameral LPS injection using a modified Hackett-McDonald scoring system.?
-
Atractylenolide I
Atractylenolide-I has an anti-inflammatory effect by inhibiting TNF-α and IL-6 production; ameliorates sepsis syndrome, liver and kidney functions by reduction of pro-inflammatory cytokines and LPS.
-
MAGE-A3 195-203
This peptide MAGE-3-encoded HLA-A24 epitope is a high MHC binder.The identification of this MAGE-3/HLA-A24 peptide may as a result effectiveially offer the opportunities to design peptide-based immunotherapeutic approaches that might prove to be potent in treating patients with MAGE-3-positive malignant tumors.
